Patient Square Capital LP
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1819257
MENLO PARK, CA
Position in ARQT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,701,400
+$262,204 QoQ
Shares Held
370,000
-7.6% QoQ
Ownership
0.294%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#50
of 271 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Patient Square Capital LP holds $625,411,079 across 22 Biotechnology names. ARQT ranks #18 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
8,020,928 | $283,860,641 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
276,000 | $51,689,280 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
260,500 | $30,496,735 | |
| 4 | ABVX |
Abivax S.A.
|
206,500 | $27,518,190 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
90,020 | $25,652,999 | |
| 6 | PHVS |
Pharvaris N.V.
|
671,209 | $23,210,407 | |
| 7 | ARGX |
Argenx SE
|
23,000 | $21,338,710 | |
| 8 | BLTE |
Belite Bio, Inc
|
110,000 | $16,938,350 |
All Filings in ARQT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,701,400 | 370,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $9,439,196 | 400,645 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,098,400 | 210,000 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||